ABSTRACT: Isothiourea HBTM-2.1 catalyzes the asymmetric Michael addition/lactonization of aryl-and alkenylacetic acids using -keto-,-unsaturated-phosphonates as ,-unsaturated ester surrogates, giving access to a diverse range of stereodefined lactones or enantioenriched functionalized diesters upon ring-opening.
Scheme 1. Initial concept
Initial investigations employed phenylacetic acid 1 and -ketophosphonate 2 in a model system and assessed a range of isothiourea Lewis base catalysts (5-7, Table 1 ). In situ formation of the mixed anhydride with pivaloyl chloride and i-Pr 2 NEt, followed by treatment with isothiourea 5 gave anti-lactone 3 in 66% isolated yield with modest ee (entry 1). A screen of isothioureas revealed HBTM-2.1 7 as the optimum catalyst, providing lactone 3 in 86% ee (entry 3). This catalyst was then examined using toluene and THF as the solvent, affording decreased isolated yields but with high diastereocontrol (entries [4] [5] . Lowering the temperature to 78 °C (entry 6) led to improved isolated yield, dr and ee. Gratifyingly, a catalyst loading of only 1 mol % at 78 °C gave the product in good yield with excellent stereocontrol (entry 7). Finally, in situ methanolysis of lactone 3 gave diester 4 and provided proof-of-principle that -ketophosphonates act as ester surrogates in this system (entry 8). 
Reaction in THF.
f Reaction at °C.
The scope and limitations of this process were next probed, initially to generate a small range of stereodefined lactones (Table 2, Conditions A). Pleasingly, both electronrich and electron-deficient arylacetic acids were suitable ammonium enolate precursors, and the functionalized lactones (3, 8-10) were isolated following Lewis base catalysis in good yield with high diastereo-and enantiocontrol. The ability of the phosphonate group to act as a masked ester/amide equivalent was assessed with a range of arylacetic acids and -ketophosphonates using a low catalyst loading of 1 mol %. The lactones were ring-opened in situ with a range of nucleophiles to reveal 1,5-diester ordiamide products (Table 2 , Conditions B) in high yield with excellent stereocontrol. Arylacetic acids containing both electron-withdrawing and electron-donating substituents in the meta-and para-positions were incorporated in high yield whilst maintaining excellent levels of enantioand diastereoselectivity (4, 11-21). 17 Extended aromatic systems were also well tolerated (16) . Additionally, -ketophosphonates containing electron-rich and electrondeficient aromatic substitution were competent in this process (17 and 18) and significantly, aliphatic substitution was also tolerated with good isolated yield and high levels of selectivity (19). Finally, allyl alcohol and i-PrNH 2 were employed in lactone ring-opening providing diester 20 and diamide 21 respectively, in excellent yields, with high enantio-and diastereocontrol.
Single crystal X-ray structure analysis of diester 15 allowed unambiguous determination of the relative and absolute configuration as (2R,3R) ( Figure 1) . 18 All other diesters within this series were assigned by analogy. Variation of the α-ketophosphonate was also explored using i-propyl phosphonate 22 (Table 3 ). The improved preparation and isolation of 22, 19 in addition to its increased bench stability over methyl phosphonate 2, allowed further examination of the substrate scope in this process. Using phosphonate 22, this methodology was amenable to large scale synthesis and diester 4 was obtained in 87% isolated yield (0.95 g, 5 mmol scale) with excellent stereocontrol. Again, a range of diester products using arylacetic acids were synthesized in excellent isolated yields, with high diastereo-and enantiocontrol (12 and 14) . Notably, the substrate scope was expanded to include heteroarylacetic and alkenylacetic acids, giving functionalized diesters 23-27 in high yield. However, the styrene 27 was isolated with diminished levels of enantiocontrol (27% ee).
To demonstrate the potential utility of this methodology, synthetic transformations of the diester products were investigated. First, complete reduction of the diester functionality was achieved by treating 4 with LiAlH 4 (1 equiv) in THF at 0 °C, giving diol 28 in quantitative yield and 99% ee (Scheme 2A). Additionally, selective reduction of the least hindered ester in 4, 12 and 14 was achieved by careful control of reaction conditions with DIBAL-H (2.2 equiv) in THF at 0 °C giving alcohols 29-31 respectively.
20
Subsequent acid catalyzed lactonization of 29-31 was achieved with TFA giving the enantiomerically enriched lactones 32-34 in good yield over two steps (Scheme 2B).
21
Such aryl-substituted -lactones are of medicinal and synthetic interest. Determined by chiral HPLC analysis.
The proposed mechanism of the process begins with Nacylation of HBTM-2.1 7 with mixed anhydride 35 formed in situ (Scheme 3). Subsequent deprotonation of 36 generates (Z)-ammonium enolate 37, which undergoes Michael addition to α-ketophosphonate 2. Lactonization regenerates the isothiourea catalyst and delivers lactone 3, which can be ring-opened in situ to afford diester 4.
In conclusion, we have demonstrated the Michael addition/lactonization of a range of acetic acids with α-keto-β,γ-unsaturated phosphonates as masked α,β-unsaturated ester equivalents. The synthetic utility of the lactone and diester products has been demonstrated through a variety of product manipulations, affording a range of stereodefined building blocks. Further studies within our laboratory are directed towards the development of isothioureas in catalysis.
Scheme 3. Proposed mechanism
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